Intravenous thrombolysis plus mechanical thrombectomy versus mechanical thrombectomy alone for acute ischemic stroke: A systematic review and updated meta-analysis of clinical trials

Abstract

Background

Mechanical thrombectomy (MT) is the gold standard treatment for large vessel occlusion (LVO). A vital factor that might influence MT outcomes is the use of intravenous thrombolysis (IVT). A few clinical trials in this domain thus far have not yielded consistent outcomes. We conducted this meta-analysis to synthesize collective evidence in this regard.

Methods

The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement guidelines were followed, and we performed a comprehensive literature search of four databases (PubMed, Scopus, Web of Science, Cochrane CENTRAL). For outcomes constituting continuous data, the mean difference (MD) and its standard deviation (SD) were pooled. For outcomes constituting dichotomous data, the frequency of events and the total number of patients were pooled as the risk ratio (RR).

Results

Seven clinical trials with a total of 2317 patients are included in this meta-analysis. Six trials are randomized, and one trial was nonrandomized. No significant differences were found between MT plus IVT and MT alone in successful recanalization (RR 1.04, 95% Confidence Interval (CI) [0.92 to 1.17], P = 0.53), 90-day functional independence (RR 1.03, 95% CI [0.90 to 1.19], P = 0.65), symptomatic intracranial hemorrhage (sICH) (RR 1.22, 95% CI [0.84 to 1.75], P = 0.30), or mortality (RR 0.94, 95% CI [0.76 to 1.18], P = 0.61).

Conclusion

The current evidence does not favor either MT plus IVT or MT alone for LVO except for the procedural time. More trials are needed in this regard, and certain factors should be considered when comparing the two approaches.

Keywords

Mechanical thrombectomy intravenous thrombolysis acute stroke large vessel occlusion

Get full access to this article

View all access options for this article.

References

Palaniswami

Yan

. Mechanical thrombectomy is now the gold standard for acute ischemic stroke: Implications for routine clinical practice. Interv Neurol 2015; 4: 18–29.

Elfil M, Bahbah EI, Bayoumi A, et al. Repeated mechanical thrombectomy for recurrent large vessel occlusion: A systematic review and meta-analysis. Interv Neuroradiol 2022. DOI: 10.1177/15910199221134307.

Ghaith HS, Elfil M, Gabra MD, et al. Intravenous thrombolysis before mechanical thrombectomy for acute ischemic stroke due to large vessel occlusion; Should we cross that bridge? A systematic review and meta-analysis of 36,123 patients. Neurol Sci 2022; 43: 6243--6269. DOI: 10.1007/s10072-022-06283-6.

Dicpinigaitis

Gandhi

Shah

, et al. Endovascular thrombectomy with and without preceding intravenous thrombolysis for treatment of large vessel anterior circulation stroke: a cross-sectional analysis of 50,000 patients. J Neurol Sci 2022; 434: 120168.

Fischer

Kaesmacher

Strbian

, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet 2022; 400: 104–115.

Huu An

Dang Luu

Duy Ton

, et al. Thrombectomy alone versus bridging therapy in acute ischemic stroke: preliminary results of an experimental trial. Clin Ter 2022; 173: 107–114.

LeCouffe

Kappelhof

Treurniet

, et al. A randomized trial of intravenous alteplase before endovascular treatment for stroke. N Engl J Med 2021; 385: 1833–1844.

Mitchell

Yan

Churilov

, et al. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial. Lancet 2022; 400: 116–125.

Suzuki

Matsumaru

Takeuchi

, et al. Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: the SKIP randomized clinical trial. JAMA 2021; 325: 244–253.

10.

Yang

Zhang

, et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med 2020; 382: 1981–1993.

11.

Qiu

, et al. Effect of endovascular treatment alone vs intravenous alteplase Plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial. JAMA 2021; 325: 234–243.

12.

Powers

Rabinstein

Ackerson

, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2019; 50: e344–e418.

13.

Desilles

Loyau

Syvannarath

, et al. Alteplase reduces downstream microvascular thrombosis and improves the benefit of large artery recanalization in stroke. Stroke 2015; 46: 3241–3248.

14.

Tsivgoulis

Katsanos

Schellinger

, et al. Successful reperfusion with intravenous thrombolysis preceding mechanical thrombectomy in large-vessel occlusions. Stroke 2018; 49: 232–235.

15.

Alves

Treurniet

Jansen

IGH

, et al. Thrombus migration paradox in patients with acute ischemic stroke. Stroke 2019; 50: 3156–3163.

16.

Kaesmacher

Boeckh-Behrens

Simon

, et al. Risk of thrombus fragmentation during endovascular stroke treatment. AJNR Am J Neuroradiol 2017; 38: 991–998.

17.

Wardlaw

Murray

, Berge E, del zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2014(7): CD000213.

18.

Moher

Liberati

Tetzlaff

, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.

19.

Higgins JPT, Thomas J, Chandler J, et al. (editors). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from: www.training.cochrane.org/handbook.

20.

Sterne

JAC

Savovic

Page

, et al. Rob 2: a revised tool for assessing risk of bias in randomised trials. Br Med J 2019; 366: l4898.

21.

Sterne

Hernan

Reeves

, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Br Med J. 2016; 355: i4919.

22.

Shehabeldin

Eby

Wallace

, et al. Effect of intravenous thrombolysis on clot survival during mechanical thrombectomy in acute large vessel occlusion strokes. Neurosurgery 2021; 89: 1027–1032.

23.

Alawieh

Vargas

Fargen

, et al. Impact of procedure time on outcomes of thrombectomy for stroke. J Am Coll Cardiol 2019; 73: 879–890.

24.

Mokin M, Waqas M, Fifi JT, et al. Intravenous alteplase has different effects on the efficacy of aspiration and stent retriever thrombectomy: analysis of the COMPASS trial. J Neurointerv Surg 2022; 14: 992–996. DOI: 10.1136/neurintsurg-2021-017943.

25.

Rinkel LA, Treurniet KM, Nieboer D, et al. Effect of Intravenous Alteplase Treatment on First-Line Stent Retriever Versus Aspiration Alone During Endovascular Treatment. Stroke 2022; 53: 3278–3288. DOI: 10.1161/STROKEAHA.121.038390.

26.

Chaturvedi

Yadav

. The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention. Stroke 2006; 37: 1572–1577.

27.

Enomoto

Yoshimura

. Antiplatelet therapy for carotid artery stenting. Interv Neurol 2013; 1: 151–163.

28.

Zinkstok

, Roos YB, investigators A. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet 2012; 380: 731–737.

29.

Marnat

Sibon

Bourcier

, et al. Thrombolysis improves reperfusion and the clinical outcome in tandem occlusion stroke related to cervical dissection: TITAN and ETIS pooled analysis. J Stroke 2021; 23: 411–419.

30.

Gory

Haussen

Piotin

, et al. Impact of intravenous thrombolysis and emergent carotid stenting on reperfusion and clinical outcomes in patients with acute stroke with tandem lesion treated with thrombectomy: a collaborative pooled analysis. Eur J Neurol 2018; 25: 1115–1120.

31.

Pikija S, Magdic J, Sztriha LK, et al. Endovascular Therapy for Tandem Occlusion in Acute Ischemic Stroke: Intravenous Thrombolysis Improves Outcomes. J Clin Med 2019; 8: 228. DOI: 10.3390/jcm8020228.

32.

Anadani

Marnat

Consoli

, et al. Endovascular therapy with or without intravenous thrombolysis in acute stroke with tandem occlusion. J Neurointerv Surg 2022; 14: 314–320.

33.

Campbell

BCV

Mitchell

Churilov

, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med 2018; 378: 1573–1582.

34.

Campbell

BCV

Mitchell

Churilov

, et al. Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized clinical trial. JAMA 2020; 323: 1257–1265.

35.

Zhou

Xing

, et al. Effect of occlusion site on the safety and efficacy of intravenous alteplase before endovascular thrombectomy: a prespecified subgroup analysis of DIRECT-MT. Stroke 2022; 53: 7–16.

36.

Lee KS, Siow I, Zhang JJY, et al. Bridging thrombolysis improves survival rates at 90 days compared with direct mechanical thrombectomy alone in acute ischemic stroke due to basilar artery occlusion: A systematic review and meta-analysis of 1096 patients. J NeuroInterv Surg 2022: jnis-2022-019510. DOI: 10.1136/jnis-2022-019510.

37.

Tao

Nogueira

Zhu

, et al. Trial of endovascular treatment of acute basilar-artery occlusion. N Engl J Med 2022; 387: 1361–1372.

38.

Jovin

, et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N Engl J Med 2022; 387: 1373–1384.

39.

Chen

Liang

, et al. Comparison of prior bridging intravenous thrombolysis with direct endovascular thrombectomy for anterior circulation large vessel occlusion: systematic review and meta-analysis. Front Neurol 2021; 12: 602370.

40.

Kaesmacher

Mordasini

Arnold

, et al. Direct mechanical thrombectomy in tPA-ineligible and -eligible patients versus the bridging approach: a meta-analysis. J Neurointerv Surg 2019; 11: 20–27.

41.

Wang

Zhu

, et al. Bridging thrombolysis achieved better outcomes than direct thrombectomy after large vessel occlusion: an updated meta-analysis. Stroke 2021; 52: 356–365.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB